ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
5.76
-0.63 (-9.80%)
Aug 20, 2026, 1:45 PM EDT - Market open
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $572.32 million as of August 20, 2026. Its market cap has decreased by -58.00% in one year.
Market Cap
572.32M
Enterprise Value
600.08M
1-Year Change
-58.00%
Ranking
Category
Stock Price
$5.76
ChartMarket Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $572.32M, an increase of 0.72%. That is a compound annual growth rate of 0.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 572.32M | -50.30% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CorMedix | 664.09M |
| Verastem | 660.66M |
| Sagimet Biosciences | 657.64M |
| Eikon Therapeutics | 650.52M |
| MiMedx Group | 648.63M |
| Valneva SE | 641.15M |
| Arvinas | 632.94M |
| Prime Medicine | 629.78M |